News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
158 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
Exergen Gears Up for Severe Cold and Flu Season
#1 Thermometer company responds to severity of 2017-2018 flu season.
January 16, 2018
·
2 min read
Drug Development
Anavex Life Sciences Reports Potential Normalization of Hypertension With ANAVEX2-73 Published in The Journal of Clinical Hypertension
Thirty-two mild-to-moderate Alzheimer’s disease patients took part in the ANAVEX2-73 Phase 2a study.
January 16, 2018
·
5 min read
Business
BioPorto: Changes in the Board of Directors - Jan. 16, 2018
The company will nominate Britt Meelby Jensen for election as a new Board member at BioPorto’s Annual General Meeting on April 13, 2018.
January 16, 2018
·
1 min read
Drug Development
First Patient Dosed in a Phase II Trial with Transgene’s TG4010 + Nivolumab + Chemotherapy for the First-Line Treatment of Lung Cancer (NSCLC)
Transgene announces the dosing of the first patient in the Phase 2 trial evaluating TG4010 in combination with Opdivo® (nivolumab) and chemotherapy as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with low or no expression of PD-L1 by the tumor cells.
January 16, 2018
·
6 min read
Pharm Country
Motif Bio Receives Award From Cystic Fibrosis Foundation
This is the first award that the Company has received from the Cystic Fibrosis Foundation.
January 16, 2018
·
7 min read
Business
HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program
The company has entered into a third statement of work for a new clinical assay development program under its Master Assay Development, Commercialization and Manufacturing Agreement with QIAGEN Manchester Limited
January 16, 2018
·
3 min read
Drug Development
Saniona Initiates Phase I Study With New Tesomet Tablet
The trial will comprise a total of 60 volunteers. Saniona expects to report results from the trial in the second quarter 2018.
January 16, 2018
·
2 min read
BioMidwest
Life Spine Achieves Monumental Sales Growth of ProLift Expandable Spacer System for 2017.
Life Spine announced today that revenues for ProLift Expandable Spacer System grew by 493% for 2017 as compared to 2016.
January 16, 2018
·
2 min read
NetScientific Portfolio Update
Over 2018 NetScientific will continue the commercial and corporate development of all its portfolio assets to maximise value.
January 16, 2018
·
4 min read
Bio NC
medi USA introduces M.4s PCL dynamic brace
Medi announced the launch of its new orthopedic knee brace, the M.4s PCL dynamic, a 4-point, rigid-frame brace with extension and flexion limitation for treating injuries of the posterior cruciate ligament.
January 16, 2018
·
2 min read
Previous
13 of 16
Next